Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹4,687 Cr₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹4,687 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹4,687 Cr
Mar2025₹7,420 Cr
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹4,687 Cr
-36.84
Mar2025 ₹7,420 Cr
3,860.66
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,730.7 Cr -1.4% -3.7% -5.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.4%

-3.7%

-5.3%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses